Research
Mixed
Obesity is a primary chronic disease driven largely by genetic predisposition, amplified by caloric intake and decreased energy expenditure, requiring recognition as a disease for proper insurance coverage and management.
Stop blaming yourself or your patients for obesity. It is a primary disease with strong genetic components. This recognition is the first step to getting proper insurance coverage and medical treatment, not just lifestyle advice.
GoodSupportsHIGH confidence
Obesity remains a primary disease by itself, often determined by genetic predisposition, and further amplified by an increased caloric intake and decreased energy expenditure.
Why this rating
Consensus statement by endocrinologists referencing twin studies and WHO data.
Source
Diagnosis and Management of Obesity: A Joint Statement by Practicing Endocrinologists
Maya Barake et al. · Journal of Diabetes Mellitus · 2023
DOI 10.4236/jdm.2023.132008
clinical_guidelineCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Lifestyle intervention (diet, physical activity, behavioral changes) is the cornerstone of obesity treatment and should be initiated in all patients, regardless of whether pharmacotherapy or surgery is added.Strong
- Pharmacotherapy for obesity is indicated for patients with BMI >= 30 kg/m2 or >= 27 kg/m2 with comorbidities, and efficacy is defined as >= 5% weight loss after 3 months.Good
- Bariatric surgery is indicated for patients with BMI >= 40 kg/m2 or >= 35 kg/m2 with comorbidities, and offers benefits beyond weight loss including glycemic control and improved life expectancy.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →